DDAVP Nasal Spray Shortage – Meeting Patients’ Needs

With the prospect of a product shortage for Desmopressin Acetate Nasal Spray extending well into 2023, The Hemophilia Alliance began searching for another source of a Desmopressin nasal spray that could meet patients’ needs. They encouraged STAQ Pharma, Inc., an FDA-registered and FDA- inspected 503B outsourcing facility located in Denver, CO, to produce the appropriate concentration of desmopressin for patient use via nasal spray route of administration. They have produced a product that has successfully passed the 75-day stability mark. They plan to start shipping on August 1st. STAQ will continue to test the product at 30-day intervals with the goal of reaching 12-month dating. 

DDAVP NS can be purchased directly from STAQ Pharma at the price of $300 per vial. For questions related to this option or reimbursement from payers, please reach out to Joe Puglilese with The Hemophilia Alliance at joe@hemoalliance.org, or contact STAQ Customer Service Representative, Martin Ramirez, at mramirez@staqpharma.com.

---